Home / Mercaptamine / Australia
AU ATC A16AA04 · updated 2 Nov 2026
Mercaptamine shortage in Australia
Is there a Mercaptamine shortage in Australia?
Yes. As of 2 Nov 2026, 1 Mercaptamine product is reported short in Australia, the first since 8 Jul 2026. The company estimate for the return is 31 Jan 2027. Main reason: not stated.
Also short in Spain. All countries.
Affected products in Australia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AU | CYSTAGON mercaptamine (cysteamine) (as bitartrate) 150mg capsule bottle | 8 Jul 2026 | 31 Jan 2027 | Not stated |
Source
Therapeutic Goods Administration (TGA), Medicine Shortage Reports Database. Official list. National shortages of reportable medicines, current and anticipated within six months; one row per product.